Alliances
A recent report by the U.S. Bureau of Labor Statistics and CBRE Research identified Seattle—which happens to be the BioSpace Bio Forest Hotbed—as the fastest-growing life science market in the top 10 from 2014 to 2017, with a greater than 17-percent growth.
In addition to the planned BioNTech IPO, many other pharma and biotech companies in Europe, Asia and elsewhere shared news for the week.
The goal is to improve the yield and quality of next-generation gene therapy vectors—typically viruses—using artificial intelligence (AI) and machine learning.
Dental manufacturer Planmeca and Navigate Surgical Technologies, a provider of real-time surgical navigation solutions, are pleased to announce their cooperation.
With Cowen & Company’s 39th Annual Health Care Conference going on in Boston this week, a lot of stories in the biopharma industry are coming out. Here are a few highlights.
The two companies will focus on utilizing the microbiome, all the bacteria, viruses and fungi in the body, to improve cancer immunotherapy.
Servier to be granted option to exclusively license one or several drug candidates as soon as they are approved to enter phase 1
NeuBase Therapeutics, Inc. announced that it has entered into definitive agreements for a $9.0 million financing that will close immediately prior to the closing of the company’s proposed merger with Ohr Pharmaceutical, Inc.
Akili receives upfront payments totalling $20 million and has the potential to receive milestone payments for Japan and Taiwan commercialisation of up to an additional $105 million, in addition to substantial royalties on product sales
STA Pharmaceutical Co., Ltd., today announced a strategic partnership for CMC development and manufacturing.
PRESS RELEASES